Tilray to import cannabis to U.S. for clinical trial

The U.S. Drug Enforcement Administration has signed off on cannabis cultivator Tilray Inc.’s plan to import a pot product from Canada to test a pot pill’s effectiveness at treating a disorder that affects millions of Americans.